Clinical Case Studies in Long-Term Care Psychiatry Navigating Common Mental Health Challenges in Geriatric Care
Book contents
- Clinical Case Studies in Long-Term Care Psychiatry
- Clinical Case Studies in Long-Term Care Psychiatry
- Copyright page
- Contents
- Preface
- Section 1 Neurocognitive Disorders
- Case 2 “I Think I Hit My Head”
- Case 3 “It’s like She’s a Different Person”
- Case 4 “I Am Tired All the Time”
- Case 5 “I Am Okay”
- Case 6 “Leave Me Alone”
- Case 7 “I Am Fine”
- Case 8 “Those Children Are Cute”
- Case 9 “Those Terrible Men Have Left”
- Case 10 “I Saw the Heavenly Gates”
- Case 11 “Leave Me Alone”
- Section 2 Mood Disorders
- Case 13 “My Mom Looks Like a Zombie!”
- Case 14 “My Soul Is in England”
- Case 15 “I Feel Terrible”
- Case 16 “I Don’t Care”
- Case 17 “I Feel Very Lonely”
- Case 18 “I Don’t Feel Right”
- Case 19 “I Am Feeling Great”
- Case 20 “I Am Staying Here Illegally”
- Section 3 Psychotic Disorders
- Case 22 “He Just Won’t Get Up”
- Case 23 “My Body Is Being Taken over by a Fungus!”
- Case 24 “This Is Humiliating”
- Case 25 “I Want to Go Home”
- Case 26 “I Am a Worrier”
- Case 27 “Get out of My House”
- Section 4 Anxiety and Related Disorders
- Case 29 “My Vision Has Been Worsening in the Last Two Weeks”
- Case 30 “I Am Not Addicted to Valium”
- Case 31 “Of Course, I Worry about Him”
- Case 32 “Bombs Are Falling! Run, Run!”
- Section 5 Substance Abuse Disorders
- Section 6 Personality Disorders
- Case 35 “I Cannot Wait to Get out of This Miserable Place”
- Section 7 Miscellaneous Neuropsychiatric Disorders Affecting Patients in Long-Term Care
- Case 37 “Everyone Is Just So Good to Me!”
- Case 38 “Why Do They Say I Have Dementia?”
- Case 39 “I Hate That Guy … I Can’t Get Any Sleep!”
- Case 40 “Just One Kiss”
- Case 41 “I Don’t Feel Well”
- Case 42 “I Like Food”
- Case 43 “I Like the Way She Laughs”
- Case 44 “This Is So Hard”
- Index
- References
Case 16 - “I Don’t Care”
SSRIs/SNRIs and Bleeding Risk
Published online by Cambridge University Press: 31 October 2024
Book contents
- Clinical Case Studies in Long-Term Care Psychiatry
- Clinical Case Studies in Long-Term Care Psychiatry
- Copyright page
- Contents
- Preface
- Section 1 Neurocognitive Disorders
- Case 2 “I Think I Hit My Head”
- Case 3 “It’s like She’s a Different Person”
- Case 4 “I Am Tired All the Time”
- Case 5 “I Am Okay”
- Case 6 “Leave Me Alone”
- Case 7 “I Am Fine”
- Case 8 “Those Children Are Cute”
- Case 9 “Those Terrible Men Have Left”
- Case 10 “I Saw the Heavenly Gates”
- Case 11 “Leave Me Alone”
- Section 2 Mood Disorders
- Case 13 “My Mom Looks Like a Zombie!”
- Case 14 “My Soul Is in England”
- Case 15 “I Feel Terrible”
- Case 16 “I Don’t Care”
- Case 17 “I Feel Very Lonely”
- Case 18 “I Don’t Feel Right”
- Case 19 “I Am Feeling Great”
- Case 20 “I Am Staying Here Illegally”
- Section 3 Psychotic Disorders
- Case 22 “He Just Won’t Get Up”
- Case 23 “My Body Is Being Taken over by a Fungus!”
- Case 24 “This Is Humiliating”
- Case 25 “I Want to Go Home”
- Case 26 “I Am a Worrier”
- Case 27 “Get out of My House”
- Section 4 Anxiety and Related Disorders
- Case 29 “My Vision Has Been Worsening in the Last Two Weeks”
- Case 30 “I Am Not Addicted to Valium”
- Case 31 “Of Course, I Worry about Him”
- Case 32 “Bombs Are Falling! Run, Run!”
- Section 5 Substance Abuse Disorders
- Section 6 Personality Disorders
- Case 35 “I Cannot Wait to Get out of This Miserable Place”
- Section 7 Miscellaneous Neuropsychiatric Disorders Affecting Patients in Long-Term Care
- Case 37 “Everyone Is Just So Good to Me!”
- Case 38 “Why Do They Say I Have Dementia?”
- Case 39 “I Hate That Guy … I Can’t Get Any Sleep!”
- Case 40 “Just One Kiss”
- Case 41 “I Don’t Feel Well”
- Case 42 “I Like Food”
- Case 43 “I Like the Way She Laughs”
- Case 44 “This Is So Hard”
- Index
- References
Summary
Antidepressants, when used appropriately and in combination with an individualized psychosocial approach, can dramatically improve depressive symptoms and the quality of life of residents who have major depressive disorder. The selection of antidepressants needs to take into account the patient’s medical problems, as well as what side effects one wants or wants to avoid for a particular patient. There is no compelling evidence that one antidepressant works better than any other for the treatment of majpr depressive disorder in long-term care populations. Selective serotonin reuptake inhibitors (SSRIs) are probably the most commonly selected first-line medications for the treatment of major depressive disorders in long-term care residents. Serotonin-norepinephrine reuptake inhibitors) have also been associated with a potentially increased risk of bleeding, although the risk appears to be lower compared to SSRIs.
- Type
- Chapter
- Information
- Clinical Case Studies in Long-Term Care PsychiatryNavigating Common Mental Health Challenges in Geriatric Care, pp. 78 - 82Publisher: Cambridge University PressPrint publication year: 2024
References
References
Joshi, A. (2018). Selective serotonin re-uptake inhibitors: An overview. Psychiatria Danubina, 30 (Suppl 7), 605–609. PMID: 30439857.Google ScholarPubMed
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., Cornett, E. M., & Kaye, A. M. (2021). Selective serotonin reuptake inhibitors and adverse effects: A narrative review. Neurology International, 13 (3), 387–401. https://doi.org/10.3390/neurolint13030038CrossRefGoogle ScholarPubMed
Edinoff, A. N., Raveendran, K., Colon, M. A., Thomas, B. H., Trettin, K. A., Hunt, G. W., Kaye, A. M., Cornett, E. M., & Kaye, A. D. (2021). Selective serotonin reuptake inhibitors and associated bleeding risks: A narrative and clinical review. Health Psychology Research, 10 (4). https://doi.org/10.52965/001c.39580Google Scholar
Anglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I. (2014). Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: A systematic review and meta-analysis. Official journal of the American College of Gastroenterology| ACG, 109 (6), 811–819.CrossRefGoogle ScholarPubMed
Isokuortti, H., Iverson, G. L., Posti, J. P., Ruuskanen, J. O., Brander, A., Kataja, A., Nikula, M., Öhman, J., & Luoto, T. M. (2021) Serotonergic antidepressants and risk for traumatic intracranial bleeding. Frontiers in Neurology, 12, 758707. Doi: 10.3389/fneur.2021.758707. PMID: 34777229; PMCID: PMC8581291.CrossRefGoogle ScholarPubMed
Jensen, M. P., Ziff, O. J., Banerjee, G., Ambler, G., & Werring, D. J. (2019) The impact of selective serotonin reuptake inhibitors on the risk of intracranial hemorrhage: A systematic review and meta-analysis. European Stroke Journal, 4 (2), 144–152.CrossRefGoogle ScholarPubMed
Cheng, Y. L., Hu, H. Y., Lin, X. H., Luo, J. C., Peng, Y. L., Hou, M. C., Lin, H. C., & Lee, F. Y. (2015). Use of SSRI, but not SNRI, increased upper and lower gastrointestinal bleeding: A nationwide population-based cohort study in Taiwan. Medicine (Baltimore), 94 (46), e2022. doi:10.1097/MD.0000000000002022CrossRefGoogle Scholar
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D. V., Jaramillo, C. L., Kasper, S., Kratiuk, K., Lee, J. G., Lee, Y., Lui, M. W., Mansur, R. B., Papakostas, G. I., & Stahl, S. (2021). Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. The American Journal of Psychiatry, 178 (5), 383. https://doi.org/10.1176/appi.ajp.2020.20081251CrossRefGoogle ScholarPubMed
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., Cornett, E. M., & Kaye, A. M. (2021). Selective serotonin reuptake inhibitors and adverse effects: A narrative review. Neurology International, 13 (3), 387–401. https://doi.org/10.3390/neurolint13030038CrossRefGoogle ScholarPubMed
Andrade, C., & Sharma, E. (2016). Serotonin reuptake inhibitors and risk of abnormal bleeding. Psychiatric Clinics, 39 (3), 413–426.Google ScholarPubMed
Further Reading
Andrade, C., & Sharma, E. (2016). Serotonin reuptake inhibitors and risk of abnormal bleeding. Psychiatric Clinics of North America, 39 (3), 413–426. doi: 10.1016/j.psc.2016.04.010. Epub 2016 Jun 28. PMID: 27514297.CrossRefGoogle ScholarPubMed
Auerbach, A. D., Vittinghoff, E., Maselli, J., Pekow, P. S., Young, J. Q., & Lindenauer, P. K. (2013). Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Internal Medicine, 173 (12), 1075–1081. doi: 10.1001/jamainternmed.2013.714. PMID: 23699725; PMCID: PMC3867199.CrossRefGoogle ScholarPubMed
Jensen, M. P., Ziff, O. J., Banerjee, G., Ambler, G., & Werring, D. J. (2019). The impact of selective serotonin reuptake inhibitors on the risk of intracranial hemorrhage: A systematic review and meta-analysis. European Stroke Journal, 4 (2), 144–152.CrossRefGoogle ScholarPubMed
Laporte, S., Chapelle, C., Caillet, P., Beyens, M. N., Bellet, F., Delavenne, X., & Bertoletti, L. (2017). Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies. Pharmacological Research, 118, 19–32.CrossRefGoogle ScholarPubMed
Lee, T., Park, Y., Kim, S., You, H., Kang, J., & Jung, Y. (2020). Concomitant use of NSAIDs or SSRIs with NOACs requires monitoring for bleeding. Yonsei Medical Journal, 61 (9), 741–749. https://doi.org/10.3349/ymj.2020.61.9.741CrossRefGoogle ScholarPubMed
McIntyre, R. S., Carvalho, I. P., Lui, L. M., Majeed, A., Masand, P. S., Gill, H., & Rosenblat, J. D. (2020). The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. Journal of Affective Disorders, 276, 576–584.CrossRefGoogle ScholarPubMed
Quinn, G. R., Hellkamp, A. S., Hankey, G. J., Becker, R. C., Berkowitz, S. D., Breithardt, G., & Singer, D. E. (2018). Selective serotonin reuptake inhibitors and bleeding risk in anticoagulated patients with atrial fibrillation: An analysis from the ROCKET AF trial. Journal of the American Heart Association, 7 (15), e008755.CrossRefGoogle ScholarPubMed